BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23882934)

  • 1. [The conversion of hypothyroidism into hyperthyroidism during leflunomide with povidone iodine treatment of rheumatoid arthritis].
    Grzywa M; Kadziela M
    Pol Merkur Lekarski; 2013 Jun; 34(204):348-50. PubMed ID: 23882934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of hyperthyroidism in burn patients treated topically with povidone-iodine.
    Rath T; Meissl G
    Burns Incl Therm Inj; 1988 Aug; 14(4):320-2. PubMed ID: 3224302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Skin ulceration after leflunomide treatment in two patients with rheumatoid arthritis].
    Jakob A; Porstmann R; Rompel R
    J Dtsch Dermatol Ges; 2006 Apr; 4(4):324-7. PubMed ID: 16638062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hyperthyroidism due to the improper use of povidone-iodine].
    Pagliaricci S; Lupattelli G; Mannarino E
    Ann Ital Med Int; 1999; 14(2):124-6. PubMed ID: 10399375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe leukopenia in a rheumatoid arthritis patient treated with a methotrexate/leflunomide combination.
    Toth P; Bernd R
    Rev Bras Reumatol; 2014; 54(2):152-4. PubMed ID: 24878863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five patients with iodine-induced hyperthyroidism.
    Rajatanavin R; Safran M; Stoller WA; Mordes JP; Braverman LE
    Am J Med; 1984 Aug; 77(2):378-84. PubMed ID: 6235747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leflunomide in combination therapy for rheumatoid arthritis.
    Savage RL
    Drug Saf; 2010 Jun; 33(6):523-6. PubMed ID: 20486733
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pleuro-pericarditis developed under a leflunomide therapy].
    Vandenbos F; Figueredo M; Tarhini A; Ribière J
    Rev Pneumol Clin; 2015 Feb; 71(1):57-9. PubMed ID: 25457216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancytopenia, including macrocytic anemia, associated with leflunomide in a rheumatoid arthritis patient.
    Toyokawa Y; Kingetsu I; Yasuda C; Yasuda J; Yoshida K; Kurosaka D; Yamada A
    Mod Rheumatol; 2007; 17(5):436-40. PubMed ID: 17929140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leflunomide-induced pulmonary hypertension in a young woman with rheumatoid arthritis: a case report.
    Alvarez PA; Saad AK; Flagel S; Mazzocchi O; Blanco MV
    Cardiovasc Toxicol; 2012 Jun; 12(2):180-3. PubMed ID: 22270725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of multiple pulmonary nodules during treatment with leflunomide.
    Yoshikawa GT; Dias GA; Fujihara S; Silva LF; Cruz Lde B; Fuzii HT; Koyama RV
    J Bras Pneumol; 2015; 41(3):281-4. PubMed ID: 26176527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leflunomide in active rheumatoid arthritis: a prospective study in daily practice.
    Van Roon EN; Jansen TL; Mourad L; Houtman PM; Bruyn GA; Griep EN; Wilffert B; Tobi H; Brouwers JR
    Br J Clin Pharmacol; 2004 Aug; 58(2):201-8. PubMed ID: 15255803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leflunomide-induced peripheral neuropathy.
    Kho LK; Kermode AG
    J Clin Neurosci; 2007 Feb; 14(2):179-81. PubMed ID: 17107800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate versus leflunomide in rheumatoid arthritis: what is new in 2011?
    Singer O; Gibofsky A
    Curr Opin Rheumatol; 2011 May; 23(3):288-92. PubMed ID: 21378570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe hypertriglygeridemia in a rheumatoid arthritis patient treated with leflunomide.
    Spanakis EK; Katsikas GA; Sidiropoulos PI; Kritikos HD
    Clin Exp Rheumatol; 2008; 26(2):382. PubMed ID: 18565269
    [No Abstract]   [Full Text] [Related]  

  • 16. [Alopecia areata secondary to the use of leflunomide in patients with rheumatoid arthritis: a case report and literature review].
    Molina Molina MI; Pinochet Paiva CM; Quezada Morales JI
    Medwave; 2015 Dec; 15(11):e6350. PubMed ID: 26819061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of long-term treatment with povidone-iodine on thyroid function.
    Nobukuni K; Hayakawa N; Namba R; Ihara Y; Sato K; Takada H; Hayabara T; Kawahara S
    Dermatology; 1997; 195 Suppl 2():69-72. PubMed ID: 9403259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
    Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
    Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage activation syndrome after leflunomide treatment in an adult rheumatoid arthritis patient.
    Ricci M; Rossi P; De Marco G; Varisco V; Marchesoni A
    Rheumatology (Oxford); 2010 Oct; 49(10):2001. PubMed ID: 20601656
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk of hepatotoxicity with add-on leflunomide in rheumatoid arthritis patients.
    Gupta R; Bhatia J; Gupta SK
    Arzneimittelforschung; 2011; 61(5):312-6. PubMed ID: 21755815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.